End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
100.50 CHF | +4.75% |
|
+4.25% | +2.84% |
02-11 | DSM-Firmenich to Sell Feed Enzymes Alliance JV Share to Partner for $1.55 Billion | DJ |
02-11 | Novonesis to buy DSM-Firmenich's stake in enzymes venture for $1.6 bln | RE |
1m. Revenue rev. | 4m. EPS revision | 4m. Revenue rev. | 1y. EPS revision | 1y. Revenue rev. | Visibility | Nbr of analysts | ||
---|---|---|---|---|---|---|---|---|
21 | ||||||||
4 | ||||||||
23 | ||||||||
15 | ||||||||
18 | ||||||||
19 | ||||||||
16 | ||||||||
15 | ||||||||
- | - | - | 1 | |||||
12 | ||||||||
4 | ||||||||
12 | ||||||||
3 | ||||||||
22 | ||||||||
6 | ||||||||
12 | ||||||||
15 | ||||||||
13 | ||||||||
11 | ||||||||
Average | 13 | |||||||
Weighted average by Cap. | 9 |
- Stock Market
- Equities
- DSFIR Stock
- Sector DSM-Firmenich
- Sector revisions

MarketScreener is also available in this country: United States.
Switch edition